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Background: The role of catheter-directed thrombolysis in the treatment of pulmonary embolism is controversial, and real world outcomes 
are unknown.
methods: We used Nationwide Inpatient Sample database from 2000 to 2012 to identify all patients aged ≥ 18 years with PE. We 
compared patients treated with CDT against the patients treated with thrombolysis alone. We used propensity score to construct two 
matched group for outcomes analysis.
results: Of 6,903 patients with PE, 1,507 were treated with CDT and 5,396 patients were treated with thrombolysis alone. Unmatched 
comparison demonstrated in-hospital mortality of 23.8% and 10.6% in patients managed with CDT vs. thrombolysis alone, respectively 
(P <0.001). We analyzed 3,939 patients with 1:2 propensity score matched pairs among CDT and thrombolysis group. After propensity 
matching, in-hospital mortality was 23.8% with CDT and 11.4% with thrombolysis alone [OR 2.445, 95% CI 2.052-2.913, P <0.001] and 
length of stay was longer in CDT group [10.72 days vs. 7.81 days (OR 1.048, 95% CI 1.037-1.058, P <0.001)].
conclusion:  In this large observation study with propensity score-matched analysis, we found that CDT is associated with higher mortality 
and length of stay compared to thrombolysis alone. Further randomized trial with outcomes such as mortality and chronic thromboembolic 
pulmonary hypertension is needed to address this difference in effectiveness.
 
